AWA
CKPT

Amplius Wealth Advisors’s Checkpoint Therapeutics CKPT Stock Holding History

Amplius Wealth Advisors’s Portfolio CKPT Stock Details CKPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-50
Closed -$1K – 296
2021
Q4 		$1K Buy
+50
New +$1.66K ﹤0.01% 879

Other funds holding CKPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
JSMC
Jess S. Morgan & Co Los Angeles, California $115M AUM 16.65% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Amplius Wealth Advisors's CKPT Position: Q1 2022 in Review

Amplius Wealth Advisors sold out of Checkpoint Therapeutics (CKPT) in Q1 2022, closing a stake of 50 shares — an estimated $1K sold.

Amplius Wealth Advisors first reported a position in CKPT in Q4 2021 and held it in 1 quarter. The position peaked at $1K in Q4 2021. 67 funds tracked by Wall St. Rank hold CKPT as of Q1 2022.

  • Amplius Wealth Advisors reported no remaining Checkpoint Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Amplius Wealth Advisors sold 50 Checkpoint Therapeutics shares in Q1 2022, an estimated $1K.
  • Amplius Wealth Advisors first reported a position in Checkpoint Therapeutics in Q4 2021 and held it in 1 quarter.
  • Amplius Wealth Advisors's Checkpoint Therapeutics position peaked at $1K in Q4 2021.
  • 67 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q1 2022.

Based on Amplius Wealth Advisors's 13F filing for Q1 2022, filed 9 May 2022.